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In rabbit ligated ileal loops, two atypical enteropathogenic Escherichia coli (aEPEC) strains, 3991-1 and
0421-1, intimately associated with the cell membrane, forming the characteristic EPEC attachment and
effacement lesion of the brush border, induced a mucous hypersecretion, whereas typical EPEC (tEPEC) strain
E2348/69 did not. Using cultured human mucin-secreting intestinal HT29-MTX cells, we demonstrate that
apically aEPEC infection is followed by increased production of secreted MUC2 and MUC5AC mucins and
membrane-bound MUC3 and MUC4 mucins. The transcription of the MUC5AC and MUC4 genes was tran-
siently upregulated after aEPEC infection. We provide evidence that the apically adhering aEPEC cells exploit
the mucins’ increased production since they grew in the presence of membrane-bound mucins, whereas tEPEC
did not. The data described herein report a putative new virulence phenomenon in aEPEC.
The intestinal mucus offers numerous ecological advantages
to bacteria present in the lumen and intestinal epithelium,
providing a source of energy by producing the saccharides used
for sustained growth by both the indigenous enteric microbiota
and pathogens (26). Moreover by producing mucus, goblet
cells contribute to the physical and chemical barriers that pro-
tect the host against the unwanted intrusion of enterovirulent
microorganisms (48). Currently, 17 human mucin-type glycopro-
teins have been assigned to the MUC gene family, MUC1 and -2,
MUC3A, MUC3B, MUC4, MUC5B, MUC5AC, MUC6 to -8,
MUC10 to -13, and MUC15 to -17, with the approval of the
Human Genome Organization Gene Nomenclature Committee
(HUGO/GNC; http://www.hugo-international.org/hugo/) (8, 9,
57). A cluster of four mucin genes (MUC2, MUC5B, MUC5AC,
and MUC6) code for secreted mucins. Eight genes (MUC1,
MUC3A, MUC3B, MUC4, MUC12, MUC13, MUC16, and
MUC17) that code for membrane-associated mucins have been
characterized. In mucin-secreting intestinal cells, the secreted mu-
cins are packaged and stored into large intracellular vesicles
(17, 39).
Pathogenic Escherichia coli causes intestinal and extraintes-
tinal diseases (35). There are six well-defined categories of
intestinal pathogenic E. coli, each characterized by specific
virulence factors that affect a wide range of cellular processes
via signaling events. Enteropathogenic E. coli (EPEC), the first
pathotype of E. coli to be described, produces characteristic
cellular lesions known as “attaching and effacing” (A/E) le-
sions in the intestinal mucosa after the bacteria have intimately
attached to the enterocyte brush border membrane and caused
cytoskeletal changes that lead to effacement of the microvilli.
The EPEC group is subdivided into typical (tEPEC) and atyp-
ical (aEPEC) forms. The aEPEC group consists of a large
number of O serogroups (29, 74). These strains have been
shown to carry the locus of the enterocyte effacement (LEE)
pathogenicity island (PAI), but to lack the EAF (EPEC adher-
ence factor) plasmid that encodes the bundle-forming pilus
(BFP) and the Shiga toxin genes (35). LEE encodes the com-
ponents of a type 3 secretion system (T3SS), an outer mem-
brane adhesive protein (intimin) and its translocated receptor
(36), and effector molecules that alter diverse cell signaling
processes (19). A large variety of serotypes and genetic viru-
lence properties have been described in aEPEC strains (29).
Several recent epidemiological studies have described in-
creasing isolation of aEPEC in diarrheic feces of children (29).
Gomes and coworkers (23) have classified the subclass of
aEPEC as an emerging group of pediatric pathogens in Brazil.
Among the aEPEC strains isolated in Brazil during an epide-
miological study, strain 3991-1, isolated from diarrheic feces,
has attracted attention as promoting mucus secretion, a phe-
notype not previously observed in an EPEC pathotype. To
investigate in vitro the production of mucins during aEPEC
infection, we used cultured, human, mucin-secreting intestinal
HT29-MTX cells (42). The regulation of mucin genes coding
for secreted or membrane-bound mucins (13, 28, 68, 79), the
production of secreted and membrane-bound mucins (28),
MUC5AC mucin exocytosis (28, 67), and the upregulation of
mucins by an enteric pathogen (6, 7, 47, 49) have previously
been reported for these cells.
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MATERIALS AND METHODS
Reagents and antibodies. Vibrio cholerae neuraminidase was purchased from
Sigma (Sigma-Aldrich Chimie SARL, L’Isle d’Abeau Chesnes, France). Oligo-
nucleotide primers were synthesized by Invitrogen. Anti-MUC2 monoclonal
antibody (MAb) and rabbit polyclonal anti-MUC3 antibody reactive against
deglycosylated MUC3 mucin were from Biomeda (Forster City, CA). Rabbit
polyclonal anti-MUC4 antibody was from C. de Bolos (Unitat de Biologica
Cellular I Molecular, Institut Municipal d’Investigacio Me`dica, Barcelona,
Spain). The anti-MUC5AC MAb 1–13 M1 was from J. Bara (Unite´ 482,
INSERM, Paris, France).
Bacterial strains. In an epidemiological study carried out in the Federal
University of Sa˜o Paulo (UNIFESP), Brazil, a collection of 59 E. coli strains
presenting the eae gene and lacking the EAF and Stx probe sequences have been
isolated (76). Among 13 of these aEPEC strains tested in the rabbit ileal loop
model, two strains, aEPEC 3991-1 and 0421-1, increased the mucus production.
aEPEC strains 3991-1 and 0421-1 were both isolated from children presenting
with acute diarrhea in whom none of the other enteropathogens tested for was
detected (rotavirus, enterotoxigenic E. coli [ETEC], enterohemorrhagic E. coli
[EHEC], enteroinvasive E. coli [EIEC], and Shigella, Salmonella, Yersinia, and
Campylobacter species). Strain 3991-1 was nontypeable for O antigens and non-
motile (ONT:H), and strain 0421-1 had the O101:H33 serotype. Moreover,
both strains 3991-1 and 0421-1 carried eae and lacked EAF and stx gene se-
quences (76), which made them capable of promoting the EPEC-like mobiliza-
tion of F-actin after interacting for 6 h with HeLa cells (Table 1). EPEC proto-
type strain E2348/69 was used as a control tEPEC strain (44). All bacterial strains
were grown in LB medium at 37°C.
Listeria monocytogenes strain EGD-SmR, a streptomycin-resistant derivative
of the EGD strain, was grown for 18 h at 37°C in brain heart infusion (BHI) broth
with streptomycin at 60 g/ml (7).
Cell-free spent culture supernatants (CFCSs) from 18-h cultures were ob-
tained by centrifugation at 10,000 g for 30 min at 4°C. Centrifuged CFCSs were
passed through a sterile 0.22-m-pore filter unit Millex GS (Millipore, Mol-
sheim, France). The filtered CFCSs were then checked to confirm the absence of
bacterial colonies by plating on tryptic soy agar (TSA) (Difco) plates.
Rabbit ligated ileal loop assay. Prior to the assays, six New Zealand White
rabbits (weighing 1.8 to 2.5 kg) (4 to 8 weeks of age) were examined for the
presence of attaching and effacing E. coli using PCR primers that identify eae
genes. The rabbit ligated ileal loop assay has been described previously (73).
Briefly, eae E. coli-free animals were fasted for 24 h before surgery. The rabbits
were sedated and anesthetized by the intramuscular injection of fentanyl (Nilp-
eridol; Cristalia, Sa˜o Paulo, Brazil) (0.3 ml/kg of body weight) and zolazepam
chloridrate (Zoletil; Virbac of Brazil) (0.4 ml/kg of body weight). After ventral
laparotomy, the mid-ileum was washed with sterile saline applied with a syringe
to eliminate intestinal feces and resident microbiota. In each rabbit, 5-cm ligated
ileal loops were constructed and separated by intervening 3-cm ligated loops. An
inoculum of 0.3 ml of a bacterial suspension (1 108 CFU/ml) or sterile medium
(LB) was inoculated into each ligated loop using a 25-gauge needle. At the end
of surgery, the animals were kept for 18 h and then killed with intravenous 3%
pentobarbital, (Hypnol; Cristalia of Brazil) and zolazepam chloridrate (Virbac of
Brazil) (0.4 ml/kg). For each ileal loop, the volume of secretion was measured
after excision. The mucous aspect of secretion was scored as follows: ,
high; , medium; , weak; and , very weak. Fragments of ileal loops
were excised and fixed for at least 24 h at 4°C in formalin at 10% for standard
Giemsa or periodic acid-Schiff (PAS) staining. The fragments were also fixed in
3% glutaraldehyde in 0.1 M sodium cacodylate pH 7.2 buffer for electron mi-
croscopy procedures. The animal experiments had been approved by the Ethical
Committee of Federal University of Sao Paulo (license no. 1506/05).
Cell lines. We used the mucin-secreting HT29-MTX cell subpopulation (42)
established from the cultured human colonic adenocarcinoma parental HT-29
cell line (16). Cells were routinely grown in Dulbecco’s modified Eagle’s minimal
essential medium (DMEM) (25 mM glucose) (Invitrogen, Cergy, France), sup-
plemented with 10% heat-inactivated (30 min, 56°C) fetal bovine serum (FBS)
(Invitrogen) (6).
The HT-29 glc/ cell subpopulation used is the HT-29 glc cell subpopula-
tion (80) established from the cultured human colonic adenocarcinoma parental
HT-29 cell line (16) and adapted for culture in the presence of glucose (43).
HT-29 glc/ cells express the structural and functional characteristics of en-
terocyte-like cells as a function of the days in culture. Cells were routinely grown
in DMEM supplemented with 20% heat-inactivated FBS.
The TC7 clone (Caco-2/TC7) (5) established from the parental human en-
terocyte-like Caco-2 cell line was used. Cells were routinely grown in Dulbecco’s
modified Eagle’s minimum essential medium (25 mM glucose) (Invitrogen),
supplemented with 15% heat-inactivated (30 min, 56°C) fetal calf serum (FCS)
(Invitrogen) and 1% nonessential amino acids (47).
For maintenance purposes, cells were passaged weekly using 0.02% trypsin in
Ca2 Mg2-free PBS containing 3 mM EDTA. Experiments and cell mainte-
nance were carried out at 37°C in an atmosphere of 10% CO2–90% air. The
culture medium was changed daily. Cultures were used at late postconfluence
(i.e., after 21 days in culture for HT29-MTX cells, and after 15 days in culture for
Caco-2/TC7 cells).
Infection of cell lines. Monolayers of cells prepared in 24-well tissue culture
plates (Corning) were washed twice with PBS, and then 1 ml of DMEM was
added. For bacterial infection, 20 l of bacterial suspension (108 CFU/ml) was
added, and the cells were incubated for 3 h at 37°C in a 10% CO2–90% air
atmosphere. In addition, after infection for 3 h, the cell monolayers were washed
4 times with sterile PBS, and then fresh cell culture medium was added, and the
infected cells were subcultured for 3 h at 37°C in a 10% CO2–90% air atmo-
sphere.
Quantification of cell-associated and internalized bacteria. For the quantita-
tive determination of the cell-associated E. coli, infected cells were washed with
sterile phosphate-buffered saline (PBS) and osmotically lysed by adding sterile
water. The suspensions were collected and appropriate dilutions plated in TSA
(Difco) plates. The colonies were counted after incubating the plates for 18 h at
37°C.
The internalization of E. coli was determined by the quantitative determina-
tion of the bacteria located within the infected cell monolayers using the genta-
micin protection assay. Infected cells were washed with sterile PBS and incu-
bated for 1 h in a medium containing 100 g/ml of gentamicin. Bacteria adhering
to the cells were rapidly killed, whereas those located within the cells were not.
The monolayer was washed once with PBS and then lysed with sterile water.
Appropriate dilutions were plated on LB agar to determine the number of viable
intracellular bacteria by bacterial colony counts.
TEM. For transmission electron microscopy (TEM), after fixing for 24 h at
4°C, the ileal fragments were rinsed with 0.1 M cacodylate buffer at pH 7.4 and
postfixed in 1% osmium tetroxide. Specimens were then exposed to a graded
series of ethanol solutions and to propylene oxide. After being embedded in
Araldite resin and being polymerized at 60°C for 48 h, ultrathin sections were
stained with 2.0% uranyl acetate aqueous solution and 2.5% lead citrate. The
specimens were then examined under a transmission electron microscope (LEO
906E; Zeiss) at 80 kV.
Immunofluorescence and confocal microscopy. Monolayers of HT29-MTX
cells were prepared on glass coverslips, which were placed in 24 well TPP tissue
culture plates (ATGC, Marne la Valle´e, France). Immunofluorescence labeling
was conducted as previously reported (47, 49). Monolayers were fixed with
methanol-acetone (vol/vol) for 3 min, and then washed 3 times with PBS. Before
MUC3 immunolabeling, the mucins were deglycosylated (3 min, 37°C, 2.25 U
Vibrio cholerae neuraminidase in 50 mM sodium acetate–150 mM sodium chlo-
ride–100 mM calcium chloride, pH 5.5, for 30 min at 37°C). Monolayers were
incubated with the primary antibody for 1 h at room temperature, washed 3 times
TABLE 1. Characteristics of bacterial strains
Strain Serotype Origin FAS testa Vol of secretion/loop (ml)
Relative mucous aspect
of secretion
HB101  0 
3991-1 NT:H Diarrhea  8.5 
0421-1 O101:H33 Diarrhea  1.5 
E2348/69 O127:H6 Diarrhea  0 
a Fluorescent actin staining test in undifferentiated HeLa cells and in fully differentiated intestinal Caco-2 cells (37).
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with PBS, and then incubated with fluorescein isothiocyanate (FITC)-conjugated
secondary antibody for 1 h.
The fluorescent actin staining (FAS) test was conducted as described by
Knutton et al. (37) using fluorescein-phalloidin (Molecular Probes, Junction
City, OR).
Specimens were mounted using Dako fluorescent mounting medium (Dako
Cytomation S.A., Trappes, France) and examined using a confocal laser scanning
microscope (CLSM; model LSM 510 Zeiss, equipped with an air-cooled argon
ion laser set at 488 nm and a 543-nm and 633-nm helium neon laser; Carl Zeiss,
Le Pecq, France) configured with an Axiovert 100 M microscope using a Plan
Apochromat 63/1.40 oil objective. Photographic images were resized and or-
ganized using Adobe Photoshop software (San Jose, CA).
MUC5AC IRMA. A solid-phase double-antibody sandwich immunoradiomet-
ric assay (IRMA) (1) was used as previously described (47, 49). Polystyrene stars
(Oris Industrie, Saclay, France) were coated with the anti-MUC5AC 1-13 M1
MAb (10 g/ml in PBS, pH 7.4) by incubation overnight at 37°C, rinsed three
times with PBS–1% bovine serum albumin (BSA)–1% Tween 20 overnight at
37°C. After washing several times, the stars were dried at 40°C and then stored
at 4°C until use. The M1/MUC5AC mucin standard (10 g/ml) and the culture
media of control unstimulated and listeriolysin O (LLO)-stimulated HT29-MTX
cells were serially diluted in PBS–0.1% Tween 20 plus 1 mM NaHCO3. A volume
of 300 l of each dilution was added to M1 MAb-coated stars 1 to 13 and
incubated overnight at 37°C. The stars were then washed with PBS–0.1% Tween
20 and incubated with PM7 MAbs previously radiolabeled overnight with 125I
(5  105 cpm/ml) at 37°C. Subsequently, the stars were washed, and the radio-
activity was measured in a gamma counter (Wizard model 147 005). The con-
centration of mucin in each sample was estimated from the IRMA standard
curve obtained with the standard M1/MUC5AC mucin.
qRT-PCR. Quantitative determination of MUC genes was conducted as pre-
viously described (Table 2) (47, 49). RNA was extracted from control and
infected HT29-MTX cells by the Trizol method. First-strand cDNA species were
synthesized using the 1st-Strand cDNA synthesis kit (Clonetech). The RNA
preparations were treated with DNase (Invitrogen) and subjected to treatment
with phenol-chloroform, after precipitation with ammonia acetate and ethanol.
The preparations were then suspended in 50 l of nuclease-free water. The
quantification and quality analysis of RNA preparations were carried out in
LabChip Agilent or in a spectrophotometer, after adequate dilutions in nuclease-
free water, subjected to electrophoresis in a 0.8% agarose gel that was observed
after staining with ethidium bromide.
Four micrograms of RNA was utilized for reverse transcription (RT) using
Supersript First-Strand Synthesis for RT-PCR kit (Invitrogen), as described by
the manufacturer, and the analysis of real-time quantitative RT-PCR (qRT-
PCR) was done using SYBR green in a light cycler thermal cycler (Roche
Diagnostics, Meylan, France) technology. For the PCRs, the Roche Plus Fast
Master kit (Roche Diagnostics) was utilized under the following operating con-
ditions: 94°C for 6 min, 45 amplification cycles at 95°C for 5 s, annealing at 65°C
for 5 s, and extension at 72°C for 7 s. The final extension was 15 min at 72°C. For
cDNA amplification, primers for mucin types previously described (22, 47, 49)
were utilized (Table 2). The first PCRs were done for the PCR standard, to check
the primer quality and to choose a standard gene. The amplification products
were subjected to electrophoresis in a 2% agarose gel that was observed after
staining with ethidium bromide.
Statistical analysis. Data are expressed as the mean standard deviation [SD]
of three separate experiments, with at least three monolayers from three suc-
cessive passages of cells per experiment. Statistical significance was assessed by
Student’s t test.
RESULTS
aEPEC strains 3991-1 and 0421-1 promote mucus secretion
in rabbit ileal loop. Infection of rabbit ligated ileal loops with
aEPEC strains 3991-1 or 0421-1 was accompanied by an in-
crease of fluid secretion 18 h postinfection (Fig. 1A and Table
1). In contrast, infection with tEPEC strain E2348/69 or E. coli
laboratory strain HB101 did not result in any increase in fluid
secretion (Fig. 1A and Table 1). Excision of rabbit ligated ileal
loops infected with aEPEC strain 3991-1 or 0421-1 revealed
the mucous aspect of the fluid secretion (Fig. 1B and Table 1).
Examination of intestinal tissue specimens after Giemsa stain-
ing revealed large clusters of aEPEC 3991-1 and aEPEC
0421-1 bacteria at the brush border of the intestinal epithelium
(Fig. 2A). A transmission electron microscopic examination of
the infected mucosa showed that aEPEC 3991-1 and aEPEC
0421-1 bacteria were intimately associated with the cell mem-
brane, forming the characteristic EPEC attachment and ef-
facement lesion of the brush border (Fig. 2B). Examination of
intestinal tissues specimens in aEPEC 3991-1- and aEPEC
0421-1-infected rabbits after periodic acid-Schiff (PAS) stain-
TABLE 2. Oligonucleotides used for MUC qRT-PCR
Gene Sequence Fragmentlength (bp) Accession no. Reference
MUC2 5 CTGCACCAAGACCGTCCTCATG 401 NM_002457 47
3 GCAAGGACTGAACAAAGACTCAGAC
MUC4 5 CGCGGTGGTGGAGGCGTTCTT 597 AJ010901 22
3 GAAGAATCCTGACAGCCTTCA
MUC5AC 5 TGATCATCCAGCAGCAGGGCT 409 AJ001402 47
3 CCGAGCTCAGAGGACATATGGG
TBP 5 GAGAGCCACGAACCACGG 178 NM_003194
3 ACATCACAGCTCCCCACCAT
FIG. 1. aEPEC strains 3991-1 and 0421-1 promote an increase in
fluid secretion in rabbit ligated ileal loops. Rabbit ligated ileal loops
received LB broth or E. coli HB101, aEPEC 3991-1, aEPEC 0421-1, or
tEPEC E2348/69 bacteria as described in Materials and Methods. The
photograph in panel A shows that fluid secretion was increased in the
presence of aEPEC 3991-1 and to a lesser extent in the presence of
aEPEC 0421-1 bacteria, but not in the presence of HB101 and tEPEC
E2348/69 bacteria. In panel B, excision of an ileal loop infected with
aEPEC 3991-1 bacteria reveals the mucin nature of the increased fluid
secretion. The photographs are representative of six rabbits examined.
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ing, showed an epithelium flattening and an increased produc-
tion of mucopolysaccharides (Fig. 2C). In contrast, the mucosa
of the tEPEC E2348/69-infected rabbit shows no increase of
PAS stain (Fig. 2C).
aEPEC strains 3991-1 and 0421-1 increased the secreted
and membrane-bound mucins in cultured, fully differentiated,
mucin-secreting human intestinal HT29-MTX cells. In order
to investigate the phenomenon of mucus secretion promoted
by aEPEC strains, experiments were conducted using the well-
established model of human mucin-secreting intestinal cells,
HT29-MTX cells in culture (42), previously used to identify the
mechanism of mucus hypersecretion by Listeria monocytogenes
(6, 7, 47, 49). Fully differentiated, HT29-MTX cells were api-
cally infected with the strains aEPEC 3991-1, aEPEC 0421-1,
and tEPEC E2348/69. Quantitative determination of the cell-
associated bacteria revealed that 3 h postinfection, cells of the
aEPEC 3991-1 and 0421-1 strains and tEPEC strain E2348/69
had adhered to the apical surface forming brush border of the
HT29-MTX cells (Fig. 3). Adhering bacteria of the aEPEC
3991-1 and 0421-1 strains and tEPEC strain E2348/69 were all
positively fluorescein-phalloidin labeled as the result of bacte-
rial recruitment of F-actin (not shown).
HT29-MTX cells expressed the MUC2 and MUC5AC genes,
which code for secreted mucins, and the MUC3 and MUC4
genes, which code for membrane-bound mucins (42, 43). We
examined the presence of the MUC2 and MUC5AC secreted
mucins in nonpermeabilized control uninfected and aEPEC-
or tEPEC-infected HT29-MTX cells by indirect immunofluo-
rescence labeling with specific antibodies followed by a CLSM
analysis (Fig. 4A). There was a marked increase in MUC5AC-
positive immunoreactivity in aEPEC 3991-1-infected cells
compared to control, uninfected cells. MUC5AC formed a
dense network that covered much of the cell surface. MUC2-
positive immunoreactivity in aEPEC 3991-1-infected cells was
greater than in control, uninfected cells. Levels of secreted
MUC2 and MUC5AC mucins rose in aEPEC 0421-1-infected
cells, but were lower than in aEPEC 3991-1-infected cells, as
characterized by several small, randomly distributed patches
positive for MUC2 or MUC5AC immunoreactivities. In con-
FIG. 2. Adhering aEPEC 3991-1 and 0421-1 bacteria formed large clusters of bacteria at the brush border of rabbit intestinal epithelium. In
panel A, Giemsa coloration of aEPEC 3991-1- or 0421-1-infected rabbit intestinal epithelium showing the randomly distributed large aEPEC
clusters. In panel B, transmission electron microscopy examination of aEPEC 3991-1- or 0421-1-infected rabbit intestinal epithelium showing the
adhering bacteria intimately associated with the cell membrane and forming the typical EPEC attachment and effacement lesion of the brush
border. In panel C, periodic acid-Schiff coloration of aEPEC 3991-1- or 0421-1-infected rabbit intestinal epithelium showing an increase of PAS
staining relative to tEPEC infected. As a negative control, infection was conducted with E. coli HB101 bacteria.
FIG. 3. Adhesion of aEPEC 3991-1 and 0421-1 strains and tEPEC
strain E2348/69 to fully differentiated, mucus-secreting HT29-MTX
cells. Cell monolayers were infected (108 CFU/ml) and incubated at
37°C in a 10% CO2–90% air atmosphere. After 3 h of infection, the
cells were lysed with sterile water for the determination of cell-asso-
ciated bacteria by a colony count assay. Each value shown is the
mean  SD from three experiments (three successive passages of
cultured cells) in triplicate. *, P  0.01 as compared with adhesion at
3 h postinfection for aEPEC 0421-1 and tEPEC E2348/69.
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trast, no increase in MUC2- or MUC5AC-positive immunore-
activities was observed in tEPEC E2348/69-infected cells.
The presence of membrane-bound MUC3 and MUC4 mu-
cins was investigated by indirect immunolabeling in control
uninfected and aEPEC- or tEPEC-infected HT29-MTX cells
(Fig. 4B). There was an increase in MUC3- and MUC4-posi-
tive immunoreactivities in aEPEC 3991-1- and 0421-1-infected
cells compared to control, uninfected cells. In contrast, MUC3-
and MUC4-positive immunoreactivities were not observed
tEPEC E2348/69-infected cells.
Consistent with the above immunofluorescence analysis, the
quantitative determination of secreted MUC5AC mucin by a
radioimmunometric assay revealed that there was 6-fold more
MUC5AC in aEPEC 3991-1-infected HT29-MTX cells than in
control, uninfected cells (Fig. 5A). The increase in MUC5AC
mucin production in aEPEC 0421-1-infected cells was lower
than that observed in aEPEC 3991-1-infected cells (Fig. 5A).
Consistent with the above immunofluorescence analysis, no
more MUC5AC mucin was secreted in tEPEC E2348/69-in-
fected cells than in control, uninfected cells (Fig. 5A). We
investigated whether secreted products of aEPEC 3991-1
and/or aEPEC 0421-1 strains supported or not the above ob-
served increase of MUC5AC mucin production. To do this, the
HT29-MTX cells were subjected to the CFCSs of aEPEC
3991-1 and/or aEPEC 0421-1 strains. As a positive control of
MUC5AC production by a bacterially secreted factor, the cells
were subjected to the CFCS of the Listeria monocytogenes
strain EGD containing the lysteriolysin O toxin inducing the
MUC5AC production in HT9-MTX cells (47, 49). No increase
in MUC5AC mucin production was observed in cells subjected
to aEPEC 3991-1 CFCS or aEPEC 0421-1 CFCS treatment
(Fig. 5B). This observation corroborates with the fact that the
aEPEC 3991-1 CFCS treatment does not induce fluid hyper-
secretion when inoculated in rabbit ileal loop (not shown).
Collectively, these results showed that the two aEPEC strains
after adhesion onto the mucin-secreting cells were able to
induce the production of both secreted and membrane-bound
mucins, a property not displayed by the prototype tEPEC
strain E2348/69.
Changes in the transcription of mucin genes in aEPEC
3991-1 or aEPEC 0421-1-infected HT29-MTX cells. We ana-
lyzed the MUC2, MUC5AC, and MUC4 genes by qRT-PCR in
control cells and aEPEC 3991-1- or aEPEC 0421-1-infected
HT29-MTX cells. As shown in Fig. 6, the transcription of the
MUC2 and MUC5AC genes coding for secreted mucins was
modified. The MUC5AC gene was transiently upregulated 3 h
postinfection and subsequently returned to normal level. Sur-
prisingly, the MUC2 gene was in fact downregulated, showing
a decrease as a function of the time postinfection. Like the
MUC5AC gene, the MUC4 gene, which codes for a membrane-
bound mucin, showed transient upregulation 3 h postinfection.
Consistent with the lack of increase in mucin production ob-
served above, transcription of the MUC2, MUC5AC, and
MUC4 genes was not modified in HT29-TX cells infected with
strain tEPEC E2348/69 (Fig. 6).
FIG. 4. Production of MUC2 and MUC5AC secreted mucins and MUC3 and MUC4 membrane-bound mucins in mucin-secreting HT29-MTX
cells infected or not with aEPEC 3991-1 or aEPEC 0421-1 or tEPEC E2348/69 strains. Indirect immunofluorescence labeling was monitored in
nonpermeabilized cells with anti-MUC2 MAb, anti-MUC5AC MAb 1-13 M1, anti-MUC3 polyclonal antibody (pAb), or anti-MUC4 pAb and
appropriate secondary FITC-conjugated antibodies. Micrographs are representative of two experiments (two successive passages of cultured cells).
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Increased mucin production does not affect cell association
or internalization of strains 3991-1 and 0421-1. Mucus pro-
duction by intestinal cells has previously been described as a
defensive response by the cell against bacterial infection
intended to inhibit the penetration into the cell of enteric
invasive pathogens (48). In order to find out whether the
aEPEC-induced production of mucin is also a cell defense
response, we compared the entry of aEPEC 3991-1 and
0421-1 bacteria into cells with different phenotypes: the
enterocyte-like HT29 glc/ cells and the mucin-secreting
HT29-MTX cells. There was no significant difference with
regard to the cell association or cell entry of aEPEC 3991-1
and 0421-1 bacteria when the levels of adhering bacteria and
those internalized within HT29-MTX and HT-29 glc/
cells were compared (Fig. 7).
Adhering aEPEC 3991-1 and 0421-1 bacteria, but not
tEPEC E2348/69 bacteria, undergo growth at the apical sur-
face of the mucin-secreting HT29-MTX cells. Mucins have
been identified as a source of nutrients for bacterial growth
(48). We therefore investigated whether the aEPEC-induced
increase in secreted and membrane-bound mucin production
had any effect on the growth of aEPEC at the cell surface of
cultured human intestinal cells. We examined whether the
increase in production of mucins modified the growth of ad-
hering aEPEC 3991-1, aEPEC 0421-1, and tEPEC E2348/69
(Fig. 8A). To do this, mucin-secreting HT29-MTX cells were
apically infected for 3 h, and then the cell-adhering bacteria
were determined. In parallel, 3-h-infected cells were washed to
eliminate any nonadhering bacteria and secreted mucins and
were cultured after for 3 h in the presence of DMEM. The
levels of adhering aEPEC 3991-1 and aEPEC 0421-1 bacteria
were all significantly increased after 3 h of infection plus wash-
ing plus 3 h of culture compared to the levels of adhering
bacteria after 3 h infection (Fig. 8A). In contrast, no increase
in the level of adhering tEPEC E2348/69 bacteria was observed
after 3 h of infection plus washing plus 3 h of culture compared
with a 3-h infection without subculture (Fig. 8A).
In the experimental condition described above, the observed
increased growth of aEPEC cells adhering onto HT29-MTX
cells after the second period of 3 h of culture could result from
the presence of membrane-bound or secreted mucins not en-
tirely released during the first 3 h infection. We next investi-
gated whether the secreted mucins alone modified the growth
of cells of the aEPEC 3991-1 and 0421-1 strains and tEPEC
strain E2348/69. To do this, bacteria were cultured in DMEM
or in the presence of DMEM culture medium of ATP-stimu-
lated HT29-MTX cells containing released preformed secreted
mucins (65). As shown in Fig. 8B, there was no significant
difference between the growth of aEPEC 3991-1 and 0421-1
and tEPEC E2348/69 cells in the presence or not of secreted
mucins. This result was confirmed in an additional experiment.
Fully differentiated Caco-2/TC7 cells which display the same
enterocyte phenotype as HT-29 glc/ cells (5, 80), were api-
cally infected for 3 h with the aEPEC 3991-1 and 0421-1 strains
or tEPEC E2348/69 strain in the presence of DMEM. In par-
allel, Caco-2/TC7 cells were infected for 3 h in the presence of
the DMEM culture medium of ATP-stimulated HT29-MTX
cells containing secreted mucins. In addition, Caco-2 cells were
preliminarily apically infected with the strains for 3 h, washed
to eliminate the nonadhering bacteria, and then subcultured
for 3 h in the presence of DMEM or DMEM culture medium
of ATP-stimulated HT29-MTX cells. As shown in Fig. 8C, the
addition of secreted mucins during infection of Caco-2/TC7
cells not significantly change the level of the adhering aEPEC
3991-1 and 0421-1 bacteria or tEPEC E2348/69 bacteria com-
pared with infection in the presence of DMEM. Moreover, the
addition of secreted mucins in preinfected Caco-2/TC7 cells
did not significantly change the level of the adhering aEPEC
3991-1 and 0421-1 or tEPEC E2348/69 bacteria compared with
preinfected cells without addition of secreted mucins. Collec-
tively, these results indicate that the growth of the adhering
aEPEC 3991-1 and 0421-1 cells, but not tEPEC E2348/69 cells,
was positively influenced by the increased production of mem-
brane-bound mucins.
FIG. 5. Production of secreted MUC5AC mucin in control mucin-
secreting HT29-MTX cells, and in cells infected with aEPEC 3991-1 or
aEPEC 0421-1 or tEPEC E2348/69 strains. Culture media of control
and infected cells were analyzed for determination of MUC5AC mu-
cin, determined by immunoradiometric assay using the anti-MUC5AC
1-13M1 and PM7 MAbs. In panel A, MUC5AC mucin in control and
cells with 3-h bacterial infection cells. In panel B, MUC5AC mucin in
cells subjected for 3 h to LB broth (control) or the cell-free spent
culture supernatant from an 18-h culture of L. monocytogenes strain
EGD or the aEPEC 3991-1, aEPEC 0421-1, or tEPEC E2348/69
strains. L. monocytogenes strain EGD CFCS was used as a positive
control for the stimulation of MUC5AC secretion in HT29-MTX by
listeriolysin O toxin (47). Each value shown is the mean  standard
error of the mean from three experiments (three successive passages of
cultured cells). Statistical analysis was performed with Student’s t test.
*, P  0.01 for L. monocytogenes EGD-infected cells compared to
control uninfected cells and aEPEC 3991-1 or aEPEC 0421-1-infected
cells.
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DISCUSSION
The results show that the aEPEC strains studied strongly
stimulated the production of the secreted MUC5AC mucin,
and slightly increased the production of secreted MUC2 mucin
in human mucin-secreting HT29-MTX cells. Moreover, we
found that the strains upregulate the MUC5AC gene. Intrigu-
ingly, despite an increased production of secreted MUC2 mu-
cin, we found that the MUC2 gene was downregulated. In
addition, our results show that the aEPEC strains upregulated
the MUC4 gene coding for a membrane-bound mucin which
has increased expression at the brush border of infected mu-
cin-secreting HT29-MTX cells. These results obtained in vitro
with mucin-secreting human intestinal cells showing the in-
creased production of secreted MUC5AC and MUC2 mucins
fits well with the observation that aEPEC strains stimulate
mucus secretion in a rabbit ileal loop model. Mucin gene
upregulation by Gram-positive and Gram-negative bacteria
has been previously reported (54). For example, increased
production of MUC2 and MUC5AC secreted mucins has been
observed in rabbit ligated ileal loops infected with Shigella
flexneri (64) and Pseudomonas aeruginosa upregulates
MUC5AC as well as MUC2 secreted mucins in both bronchial
explants and cultured airway epithelial cells via an NF-B and
Src-dependent Ras-mitogen-activated protein kinase (MAPK)-
pp90rsk pathways (11, 45, 46) or promotes the production of
reactive oxygen species (ROS) triggering the release of trans-
forming growth factor alpha (TGF-	), which in turn, upregulates
MUC5AC production (78). Untypeable Haemophilus influenzae
strongly induces upregulation of MUC5AC mucin via activation
of the Toll-like receptor 2-MyD88-dependent p38 pathway (33).
Several toxin-dependent upregulations of intestinal mucins
have previously been reported. Vibrio cholerae enterotoxin, by
increasing intracellular adenosine 3,5-cyclic monophosphate,
increases mucus secretion from intestinal goblet cells both in
vitro and in vivo (14, 32, 40, 41). The wild-type L. monocyto-
genes strain EGD increases mucus secretion in vivo (63), with
the result that listeriolysin O toxin promotes the increased
production of secreted and membrane-bound mucins and the
upregulation of MUC genes in cultured mucin-secreting HT29-
MTX cells (6, 7, 47). Moreover, Streptococcus pneumoniae
pneumolysin has been shown to promote the upregulation of
MUC5AC mucin via TLR4-dependent activation of ERK and
an IB kinase-dependent signaling mechanism in human epi-
thelial cells in vitro and in mice in vivo (25). Results reported
here showing that CFCSs of aEPEC strains failed to induce
any increase of MUC5AC mucin secretion indicate that the
mucus-secreting effect on the aEPEC strain did not result from
an aEPEC-associated toxin.
Hypersecretion of mucus is not a general trait observed for
EPEC infection, although Fagundes-Neto and Scaletsky (15)
have reported that surface abnormalities of the small intestinal
mucosa of EPEC-infected patients were accompanied by the
presence of a mucus pseudomembrane coating the mucosal
surface. Recently, it has been reported that the related EPEC
and EHEC mouse pathogen Citrobacter rodentium, which in-
fects the apical surfaces of enterocytes and promotes attaching
FIG. 6. Determination of MUC2, MUC5AC, and MUC4 mucin mRNA expression in control mucin-secreting HT29-MTX cells and in cells
infected with the aEPEC 3991-1, aEPEC 0421-1, or tEPEC E2348/69 strains. qRT-PCR was monitored as described in Materials and Methods.
Noninfected HT29-MTX cells have a value of 1. Each value shown is the mean  standard error of the mean from three experiments (three
successive passages of cultured cells).
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and effacing (A/E) lesions, via the host immune system mod-
ulates the function of goblet cells, leading to a dramatic de-
pletion of mucus (2). The nature of the virulence factor of
aEPEC strains that increases the secretion of intestinal mucus
both in vitro and in vivo remains to be determined. It was
noticed that this effect seems to be specific to aEPEC strains,
since no increase of secreted mucins develops in human intes-
tinal mucus-secreting cells infected with tEPEC strain E2348/
69. On the basis of the results reported here showing that
aEPEC intimately attached to the cell membrane of mucin-
secreting intestinal HT29-MTX cells triggered an increase in
mucin production, we postulate that the observed aEPEC-
induced mucin production could be a T3SS-dependent event.
Several aEPEC strains promoted the actin cytoskeleton reor-
ganization via the TccP2/EspU-dependent actin-signaling cas-
cade (60). TccP2/EspU, which was first identified in EHEC
(20), but is also present in non-O157 EHEC, and in tEPEC and
aEPEC isolates, particularly in strains belonging to serogroups
O26 (EHEC), O119 (tEPEC), and O55 (aEPEC) (21), displays
an Nck-like activity that is essential for promoting actin poly-
merization (4) and is translocated into the infected cell cyto-
plasm through the LEE-encoded filamentous T3SS needle. In
EPEC/EHEC (19), TSS3-dependent translocation of effector
proteins such as Tir, Map, EspF, EspG, EspH, SepZ, and EspB
means that these pathogens subvert cell signaling pathways
either to modify the polarized organization of the host cells
and/or to alter specific intestinal functions. The observation
here that a tEPEC strain fails to induce the increase in mucin
production suggests that the known tEPEC TSS3-dependent
effectors are not involved in the aEPEC-induced increase in
mucin production. Interestingly, seven potential TSS3-related
effectors, designated NleB to -H with unknown functions and
encoded outside the LEE by three uncharacterized PAIs, sug-
gesting that they could act cooperatively with the LEE in
pathogenesis, have been identified in EHEC (10). It could be
interesting in the future to find out whether the suspected
aEPEC, TSS3-dependent effector triggering the mucin upregu-
lation is one of these effectors or not.
Specialized epithelial cells constitute the first line of host
innate defense against invading and noninvading microbes by
elaborating a range of molecules, including mucins that are
involved in pathogen clearance (48). For example, in response
to bacterial infection, the Paneth cells discharge antimicrobial
peptides into the intestinal luminal space, one of which is the
antibacterial peptide cathelicidin, increasing mucus synthesis
by activating mitogen-activated protein kinase (71). The mucus
coating the intestinal epithelium creates an exclusion barrier
effect due to the dense glycosylated layer. Lievin-Le Moal et al.
(49) have reported that in HT29-MTX cells the LLO toxin of
L. monocytogenes induced an increase in mucin exocytosis that
creates a gel of mucins over the apical cell surface, which in
turn decreases the cell entry of Listeria monocytogenes. More-
over, it has been reported previously that intestinal mucins
inhibit the cell attachment of the rabbit EPEC-related strain
RDEC-1 strain (12, 52). A similar inhibition of adhesion by
mucus has been observed for the human EPEC strain
E2348/69 (69), and it is interesting to note that the probiotic-
induced hyperproduction of MUC2 and MUC3 mucins leads
to the inhibition of EPEC attachment to host cells (51). In
addition, the mucus has a protective role against the deleteri-
ous effect of enteric pathogens on intestinal cells, since no
increase in TNF-	 mRNA occurs in Shigella flexneri-infected
HT29-MTX or HT29-FU mucin-secreting cells, in contrast to
infected enterocyte-like HT-29 glc cells (59). It is interesting
to note that several gastrointestinal pathogens have developed
sophisticated strategies, including specific pathogenic factors,
to escape this host defense mechanism. The prototype of these
pathogens is Helicobacter pylori, which uses its flagella for
growth and motility within the mucus layer (61), reduces gas-
tric mucin synthesis (72) and mucin exocytosis (55), and causes
the aberrant production of the gastric mucins MUC1,
MUC5AC, and MUC6 (3, 58). It has been demonstrated that
one aEPEC strain expressing the intimin subtype omicron was
more invasive than tEPEC in undifferentiated, nonintestinal
HeLa and Hep-2 cells (30). Consistent with what was previ-
ously reported for tEPEC (18), aEPEC strains were invasive in
undifferentiated human intestinal Caco-2 cells and weakly in-
vasive in differentiated enterocyte-like cells (66). Intriguingly,
the aEPEC 0621-6, 1632-7, and 1871-1 strains showed a signif-
icant invasiveness capacity in the differentiated cryptic-like T84
cells in contrast with the typical tEPEC E2348/69 strain (77).
Our results indicate that aEPEC-induced increased production
of mucins is not a protective cell response against aEPEC
infection of the intestinal cells. Indeed, investigating the con-
sequences of the aEPEC-induced hyperproduction of secreted
FIG. 7. Association of aEPEC 3991-1 and 0421-1 bacterial cells
with and internalization within mucin-secreting HT29-MTX cells and
enterocyte-like HT-29 glc/ cells. Cell monolayers were infected (108
CFU/ml) and incubated for 3 h at 37°C in a 10% CO2–90% air atmo-
sphere. For the determination of cell-associated bacteria, infected cells
were washed with sterile PBS and lysed with sterile water. To deter-
mine the internalized bacteria, the infected cells were washed with
sterile PBS, incubated for 1 h in a medium containing 100 g/ml of
gentamicin to kill extracellular bacteria, and lysed with sterile water.
Appropriate dilutions were plated on LB agar to determine the num-
ber of viable intracellular bacteria by bacterial colony counts. Each
value shown is the mean  SD of three experiments (three successive
passages of cultured cells).
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and membrane-bound mucins in mucin-secreting HT29-MTX
cells in terms of cell association and internalization, we found
that aEPEC strains cell associated and internalized similarly
when infection was conducted with the mucin-secreting HT29-
MTX cell line and enterocyte-like HT29 glc/ or Caco-2/TC7
cell lines.
Despite the known role of mucus in the host’s innate defense
against invading and noninvading microbes, mucus has also
been identified as being a source of nutrients for bacterial
growth (48). Yersinia enterocolitica growth was enhanced in the
presence of mucus (53). Salmonella and Escherichia coli grew
in vitro utilizing glycolytic and gluconeogenic substrates and
the lipids derived from mucus as a source of carbon and ni-
trogen (38, 56). Moreover, growing Lactobacillus reuteri strains
in the presence of mucin dramatically improved their mucus-
binding activity (34). Macfarlane et al. (50), who examined the
role of the mucus layer coating the human large intestine, have
concluded that intestinal bacterial populations growing on mu-
cin surfaces are distinct from their planktonic counterparts
present in the gut lumen, in particular in terms of colonization.
Consistent with this, it has been observed that inoculating the
methicillin-resistant Staphylococcus aureus into the colonic mu-
cus layer leads to rapid bacterial growth, facilitating the intes-
tinal colonization of mice (24). In the same way, Campylobacter
jejuni utilizes the secreted MUC2 mucin as an environmental
cue for modulating the expression of genes with various func-
tions including colonization and pathogenicity (75). Pseudomo-
nas aeruginosa seems to induce a similar induction of mucin
production in airway diseases. Via reactive oxygen species, P.
aeruginosa upregulates MUC5AC mucin production (78) and
utilizes the sputum layer of the cystic fibrosis lung as a carbon
and energy source to support its high-density growth during
chronic colonization (62). Motility allows Salmonella enterica
serovar Typhimurium to benefit from released high-energy
nutrients, including galactose-containing glycoconjugates and
mucins for enhancing its own growth in the inflamed intestine
(70). Harrington et al. (27) have recently reported that the
prototype enteroaggregative E. coli strain 042 colonized the
FIG. 8. Growth of aEPEC 3991-1 and 0421-1 and tEPEC E2348/69 bacteria in the presence of secreted and/or membrane-bound mucins. Cell
monolayers were infected (5  107 CFU/ml) and incubated at 37°C in a 10% CO2–90% air atmosphere. In panel A, after the secreted mucins had
been eliminated by washing from infected HT29-MTX cells, an increased growth of adhering aEPEC 3991-1 and 0421-1 cells, but not of the tEPEC
E2348/69 bacteria, develops. Panel B shows growth of aEPEC 3991-1, aEPEC 0421-1, and tEPEC E2348/69 bacteria (2  107 CFU/ml) in DMEM
or in the presence of DMEM culture medium of ATP-stimulated HT29-MTX cells containing secreted mucins. Panel C shows growth of aEPEC
3991-1 and 0421-1 cells and tEPEC E2348/69 bacteria that adhered to enterocyte-like Caco-2/TC7 cells in the presence or not of HT29-MTX
secreted mucins. Each value shown is the mean  SD of three experiments (three successive passages of cultured cells). *, P  0.01 as compared
to the adhesion 3 h postinfection plus washing.
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intestine of streptomycin-treated mice by a mechanism involv-
ing the Pic serine protease autotransporter of Enterobacteria-
ceae mucinase toxin that favors the bacterial growth in the
presence of secreted cecal mucus. In the study reported here,
we used two sets of experimental conditions to investigate
whether the human secreted and/or membrane-bound mucins
play any role in the growth of aEPEC and tEPEC apically
infecting enterocyte-like or mucin-secreting human intestinal
cells. We observed that in HT29-MTX cells which express
mucins into the culture medium and which have an apical
surface that forms a brush border expressing membrane-bound
mucins, an increase in the levels of adhering aEPEC strains
developed under the subculture condition, whereas tEPEC did
not. Using the secreted mucins pharmacologically released
from HT29-MTX, we observed that these mucins did not mod-
ify the levels of aEPEC and tEPEC adhering onto the entero-
cyte-like Caco-2/TC7 cells. This suggests that aEPEC could
possess several enzymatic systems that allow them to break
down membrane-bound mucins to generate substrates facili-
tating bacterial growth. Interestingly, desulfatation activity has
been identified in P. aeruginosa, and the desulfatation of mucin
increases its susceptibility to degradation by bacterial glycosi-
dases and proteinases, and subsequent deglycosylation facili-
tates bacterial colonization by increasing the substrates avail-
able (31).
In conclusion, we provide evidence that the aEPEC strains
studied interact with human mucin-secreting polarized intesti-
nal HT29-MTX cells to induce the increased expression of
MUC genes coding for secreted or membrane-bound mucins,
stimulate exocytosis of secreted mucins, and elevate the level
of membrane-bound mucins at the apical cell surface forming
the brush border. In contrast, this effect is not produced by a
tEPEC strain. We also demonstrated that the increased pro-
duction of mucins is not a cell defense response to aEPEC
infection, but favors the growth of adhering aEPEC bacteria at
the apical cell surface of the mucin-secreting cells. The
aEPEC-specific effector that is not a secreted effector, which
activates a mucin regulatory signaling pathway within the cells,
remains to be identified.
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